Evidence map›Paper›PMID 42263215›Full record

ArticleJournal of food science2026

Effects of Lysozyme and Silver Anode Treatment on Pseudomonas aeruginosa Growth and Biofilm Formation in Raw Milk.

Sergul Cibik, Ayhan Duran

Abstract read
In one paragraph

Article in Journal of food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sergul CibikDepartment of Food Engineering, Faculty of Engineering, Aksaray University, Aksaray, Turkey.ORCID https://orcid.org/0000-0002-0997-3912
Ayhan DuranDepartment of Food Engineering, Faculty of Engineering, Aksaray University, Aksaray, Turkey.ORCID https://orcid.org/0000-0002-4042-0988

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas aeruginosa is an important spoilage‑associated and opportunistic pathogen in raw milk, producing heat‑stable enzymes and robust biofilms that resist conventional sanitation. The limitations of existing decontamination methods necessitate novel, nonthermal, and ecofriendly strategies. This study evaluated the antibacterial and anti‑biofilm effects of lysozyme combined with the silver anode technique (SAT) against P. aeruginosa ATCC 27853 in raw milk. The minimum inhibitory concentration (MIC) of lysozyme was estimated by disk diffusion (8 g/100 mL). Raw milk samples were assigned to eight experimental groups: untreated controls, lysozyme alone, SAT alone, and their combination. Bacterial counts (log CFU/mL) and biofilm formation (crystal violet assay) were monitored over 72 h of refrigerated storage, and silver ion migration was quantified by ICP‑MS. Lysozyme alone was predominantly bacteriostatic, while SAT alone produced a bactericidal reduction (up to 1.5-2 log). The combination reduced planktonic counts by up to 2.5 log and biofilm by up to 78%. These reductions were greater than either treatment alone, although the effect was additive, not strictly synergistic. Silver migration (3.88 µg/L) gave a daily intake of 0.055 µg/kg for an adult consuming 1 L, well below EPA (5 µg/kg/day) and EFSA (50 µg/kg food) limits. The combination offers an effective, non‑thermal, eco‑friendly dairy pretreatment strategy. It can extend shelf life, reduce biofilm contamination, and minimize chemical disinfectants, aligning with green technology.

Indexed as

Anti-Bacterial AgentsBiofilmsMilkMuramidasePseudomonas aeruginosaSilverAnimalsColony Count, MicrobialElectrodesMicrobial Sensitivity TestsAnti-Bacterial AgentsMuramidaseSilverbiofilmlysozymePseudomonas aeruginosaraw milksilver anode

Identifiers

PMID42263215
PMCPMC13249356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.